Racial difference in mortality among COVID-19 hospitalizations in California.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
22
08
2022
accepted:
09
11
2023
medline:
6
12
2023
pubmed:
5
12
2023
entrez:
4
12
2023
Statut:
epublish
Résumé
In the US, racial disparities in hospital outcomes are well documented. We explored whether race was associated with all-cause in-hospital mortality and intensive care unit (ICU) admission among COVID-19 patients in California. This was a retrospective analysis of California State Inpatient Database during 2020. Hospitalizations ≥ 18 years of age for COVID-19 were included. Cox proportional hazards with mixed effects were used for associations between race and in-hospital mortality. Logistic regression was used for the association between race and ICU admission. Among 87,934 COVID-19 hospitalizations, majority were Hispanics (56.5%), followed by White (27.3%), Asian, Pacific Islander, Native American (9.9%), and Black (6.3%). Cox regression showed higher mortality risk among Hispanics, compared to Whites (hazard ratio, 0.91; 95% CI 0.87-0.96), Blacks (hazard ratio, 0.87; 95% CI 0.79-0.94), and Asian, Pacific Islander, Native American (hazard ratio, 0.89; 95% CI 0.83-0.95). Logistic regression showed that the odds of ICU admission were significantly higher among Hispanics, compared to Whites (OR, 1.70; 95% CI 1.67-1.74), Blacks (OR, 1.70; 95% CI 1.64-1.78), and Asian, Pacific Islander, Native American (OR, 1.82; 95% CI 1.76-1.89). We found significant disparities in mortality among COVID-19 hospitalizations in California. Hispanics were the worst affected with the highest mortality and ICU admission rates.
Identifiants
pubmed: 38049452
doi: 10.1038/s41598-023-47124-6
pii: 10.1038/s41598-023-47124-6
pmc: PMC10696031
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21378Informations de copyright
© 2023. The Author(s).
Références
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
JAMA Netw Open. 2021 Oct 1;4(10):e2130479
pubmed: 34673962
BMJ Open. 2020 Aug 11;10(8):e039849
pubmed: 32784264
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
J Gen Intern Med. 2020 Oct;35(10):3097-3099
pubmed: 32754782
Int J Obes (Lond). 2021 May;45(5):998-1016
pubmed: 33637951
Health Aff (Millwood). 2021 Jun;40(6):870-878
pubmed: 33979192
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331343
Clin Infect Dis. 2021 Dec 6;73(11):e4131-e4138
pubmed: 32827436
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Int J Mol Sci. 2020 May 14;21(10):
pubmed: 32423094
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503
pubmed: 32658868
Front Med (Lausanne). 2022 May 12;9:850536
pubmed: 35646954
Ann Am Thorac Soc. 2020 Oct;17(10):1336-1339
pubmed: 32643398
Ann Epidemiol. 2020 Dec;52:46-53.e2
pubmed: 32711053
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147
Lancet. 2020 May 2;395(10234):1421-1422
pubmed: 32330427
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901